Cargando…

Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation

Rosiglitazone (RGZ), a peroxisome proliferator-activated receptor gamma (PPARγ) ligand, has been reported to act as insulin sensitizer and exert cardiovascular actions. In this work, we hypothesized that RGZ exerts a PPARγ–dependent regulation of blood pressure through modulation of angiotensin-conv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Aguilar, María, Ibarra-Lara, Luz, Del Valle-Mondragón, Leonardo, Rubio-Ruiz, María Esther, Aguilar-Navarro, Alicia G., Zamorano-Carrillo, Absalom, Ramírez-Ortega, Margarita del Carmen, Pastelín-Hernández, Gustavo, Sánchez-Mendoza, Alicia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378057/ https://www.ncbi.nlm.nih.gov/pubmed/30863432 http://dx.doi.org/10.1155/2019/1371758

Ejemplares similares

Nonclassical Axis of the Renin-Angiotensin System and Neprilysin: Key Mediators That Underlie the Cardioprotective Effect of PPAR-Alpha Activation during Myocardial Ischemia in a Metabolic Syndrome Model
por: Sánchez-Aguilar, María, et al.
Publicado: (2020)

Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II
por: Ibarra-Lara, Luz, et al.
Publicado: (2016)

Extracts of Crataegus oxyacantha and Rosmarinus officinalis Attenuate Ischemic Myocardial Damage by Decreasing Oxidative Stress and Regulating the Production of Cardiac Vasoactive Agents
por: Cuevas-Durán, Raúl Enrique, et al.
Publicado: (2017)

Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro
por: Ren, Liqun, et al.
Publicado: (2011)

Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects
por: Cortes-Lopez, Fabiola, et al.
Publicado: (2021)

Clofibrate Treatment Decreases Inflammation and Reverses Myocardial Infarction-Induced Remodelation in a Rodent Experimental Model
por: Ibarra-Lara, Luz, et al.
Publicado: (2019)

Rosiglitazone activation of PPARγ suppresses fractalkine signaling
por: Wan, Yihong, et al.
Publicado: (2010)

Fenofibrate plus Metformin Produces Cardioprotection in a Type 2 Diabetes and Acute Myocardial Infarction Model
por: Oidor-Chan, Víctor Hugo, et al.
Publicado: (2016)

OR04-5 Stimulation of Protein Disulfide Isomerase Activity by Activation of The Renin-Angiotensin System
por: Irizarry, Jose, et al.
Publicado: (2019)

Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
por: Cellai, I, et al.
Publicado: (2006)

Role of Vascular Smooth Muscle PPARγ in Regulating AT(1) Receptor Signaling and Angiotensin II-Dependent Hypertension
por: Carrillo-Sepulveda, Maria Alicia, et al.
Publicado: (2014)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
por: Ferri, Claudio, et al.
Publicado: (2021)

The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis
por: Ramakers, Julian D., et al.
Publicado: (2007)

The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
por: Wang, Zhenyu, et al.
Publicado: (2020)

PPAR Alpha Activation by Clofibrate Alleviates Ischemia/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response
por: Sánchez-Aguilar, María, et al.
Publicado: (2023)

The renin–angiotensin system and diabetes: An update
por: Ribeiro-Oliveira, Antônio, et al.
Publicado: (2008)

Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

The Renin-Angiotensin System Textbook
por: Cumming, Allan D
Publicado: (1994)

Brain renin angiotensin in disease
por: Phillips, M. Ian, et al.
Publicado: (2008)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model
por: Guzeloglu, Mehmet, et al.
Publicado: (2012)

Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone
por: Cheng, Wing Yin, et al.
Publicado: (2016)

Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients
por: Caro-Codón, Juan, et al.
Publicado: (2022)

Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions
por: Catarata, Maria Joana, et al.
Publicado: (2020)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

Local renin angiotensin system and sperm DNA fragmentation
por: Aparicio Prieto, María Victoria, et al.
Publicado: (2021)

Combination of β Adrenergic Receptor Block and Renin–Angiotensin System Inhibition Diminished the Angiotensin II-Induced Vasoconstriction and Increased Bradykinin-Induced Vasodilation in Hypertension
por: Lezama-Martínez, Diego, et al.
Publicado: (2017)

ANGIOTENSIN AND RENIN IN RAT AND DOG BRAIN
por: Fischer-Ferraro, Catalina, et al.
Publicado: (1971)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Within the Brain: The Renin Angiotensin System
por: Jackson, LaDonya, et al.
Publicado: (2018)

Renin-Angiotensin System and Cardiovascular Functions
por: Wu, Chia-Hua, et al.
Publicado: (2018)

COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020)

Role of the Renin-Angiotensin System in ARDS
por: Zambelli, V., et al.
Publicado: (2012)

Effects of Statins on Renin–Angiotensin System
por: Kiaie, Nasim, et al.
Publicado: (2021)

Nanoparticle approaches for the renin-angiotensin system
por: Hettiarachchi, Sajini D., et al.
Publicado: (2023)

The Adipose Renin-Angiotensin System Modulates Systemic Markers of Insulin Sensitivity and Activates the Intrarenal Renin-Angiotensin System
por: Kim, Suyeon, et al.
Publicado: (2006)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Induction of PPAR Gamma mRNA and Protein Expression by Rosiglitazone in Chronic Cyclosporine Nephropathy in the Rat
por: Ahn, Kyung Ohk, et al.
Publicado: (2007)

Electroacupuncture Reduces Weight Gain Induced by Rosiglitazone through PPARγ and Leptin Receptor in CNS
por: Jing, Xinyue, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4kgneplp08phg8k82olgd0kheo